ISSN:
1432-0843
Keywords:
Key words Lung cancer
;
Paclitaxel
;
Docetaxel
;
CPT-11
;
Topotecan
;
Vinorelbine
;
Gemcitabine
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract A number of new drugs and drug classes have recently become available for clinical testing which demonstrate significant antitumor activity in non-small cell lung cancer. The preclinical rationale, mechanism of action, toxicity profile and results of early trials of paclitaxel, docetaxel, edatrexate, CPT-11, topotecan, vinorelbine and gemcitabine in non-small cell lung cancer are reviewed.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/s002800050402
Permalink